2024年2月15日 · The dose of INVANZ in patients 13 years of age and older is 1 gram (g) given once a day. 3 months to 12 years of age The dose of INVANZ in patients 3 months to 12 years of age is 15 mg/kg twice daily (not to exceed 1 g/day).

1 g/day IV/IM for 7-14 days; may be continued up to 4 weeks for diabetic foot infections, depending on severity of infection and response to therapy (treatment excludes diabetic...

INVANZ®(Ertapenem for Injection)是一無菌、合成、長效、注射用的1-β methyl-carbapenem ，它的化學結構與β-lactam 類抗生素(例如penicillins 和 cephalosporins)相似，能廣泛對抗多種革蘭氏陽性和革蘭氏陰性需氧菌和厭氧菌。

INVANZ is indicated for the treatment of adult patients and pediatric patients (3 months of age and older) with community acquired pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only)

The dose of Invanz in patients 13 years of age and older is 1 gram (g) given once a day; in younger patients (3 months to 12 years of age) the dose is 15 mg/kg twice daily (not to exceed 1 g/day). Invanz may be administered by intravenous infusion for up to 14 days or by intramuscular injection for up to 7 days.

INVANZ∗ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1- β methyl-carbapenem that is structurally related to beta-lactam antibiotics. Chemically, INVANZ is described as [4 R...

2024年6月30日 · Adults and teenagers—1 gram (g) injected into a vein or injected into a muscle once a day. Your doctor will determine your injection site and the length of time that you will take it. Children and infants (3 months to 12 years of age)—Dose is based on body weight and must be determined by your doctor.

INVANZ is indicated for the treatment of complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides...

2024年2月20日 · INVANZ is a penem antibacterial indicated in adult patients and pediatric patients (3 months of age and older) for the treatment of the following moderate to severe infections caused by susceptible bacteria: INVANZ is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery. (1.6)

2003年6月16日 · INVANZ適用於治療病患由具感受性之微生物所引起的中度至重度感染，而且適用於下列感染在尚未鑑定出病原菌之前按經驗的治療處理 (EMPIRIC THERAPY)：1.複雜的腹腔內感染 2.複雜的皮膚和皮膚組織感染 3.感染性肺炎 (COMMUNITY ACQUIRED PNEUMONIA) 4.複雜的尿道感染，包括腎盂腎炎 5.急性骨盆感染，包括產後子宮內肌炎、敗血性流產和手術後婦科感染。 《本藥典資料定期與衛生福利部食品藥物管理署（TFDA）藥品資料庫進行同步更新，若您查 …